Phase III clinical trial results for corticosteroid flucinolone acetonide insert reports statistically significant results
Results from a Phase III study to evaluate the safety and efficacy of an injectable fluocinolone acetonide intravitreal insert (FAI, “Medidur”), for the treatment of… Read More »Phase III clinical trial results for corticosteroid flucinolone acetonide insert reports statistically significant results